# Valle Del Sol, Inc.

Health Center, AZ
Page: https://astrelis.co/providers/health_center/031001  
This twin: https://astrelis.co/providers/health_center/031001.md  
CMS Certification Number (CCN): 031001  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2020 to 2025)

Filings that are not a full fiscal year: FY2020 covers 205 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 11,582. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -50.2%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 36. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 19.4%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $63.5M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -50.2%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Valle Del Sol, Inc., AZ

Match to this profile: matched by name (method: name and state).

- FY ending 2025-06-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-06-GSAFAC-0000411097
- FY ending 2024-06-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-06-GSAFAC-0000364113
- FY ending 2023-06-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-06-GSAFAC-0000049036

| Line | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 1,501,674 [derived, p.6] | 4,080,323 [derived, p.6] | 1,476,733 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 4,917,528 [derived, p.6] | 2,378,208 [derived, p.6] | 1,701,339 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 1,107,151 [derived, p.6] | 1,095,600 [derived, p.6] | 2,893,614 [derived, p.6] |
| other current assets (Statement of financial position) | 256,713 [derived, p.6] | 168,953 [derived, p.6] | 160,465 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 7,783,066 [extracted, p.6] | 7,723,084 [extracted, p.6] | 6,232,151 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 6,150,429 [derived, p.6] | 5,243,340 [derived, p.6] | 6,495,157 [derived, p.6] |
| other long-term assets (Statement of financial position) | 21,395,784 [derived, p.6] | 20,830,282 [derived, p.6] | 22,131,793 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 35,329,279 [extracted, p.6] | 33,796,706 [extracted, p.6] | 34,859,101 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 8,097,041 [derived, p.7] | 7,299,683 [derived, p.7] | 4,024,606 [derived, p.7] |
| deferred revenue (Statement of financial position) | 2,657,916 [derived, p.7] | 2,257,941 [derived, p.7] | 1,045,784 [derived, p.7] |
| current debt and leases (Statement of financial position) | 2,453,540 [derived, p.7] | 640,441 [derived, p.7] | 663,356 [derived, p.7] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 13,208,497 [extracted, p.7] | 10,198,065 [extracted, p.7] | 5,733,746 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | 24,727,099 [derived, p.7] | 23,826,390 [derived, p.7] | 26,038,523 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 37,935,596 [extracted, p.7] | 34,024,455 [extracted, p.7] | 31,772,269 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | -3,309,440 [derived, p.7] | -2,126,697 [derived, p.7] | 1,213,740 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | 703,123 [derived, p.7] | 1,898,948 [derived, p.7] | 1,873,092 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | -2,606,317 [extracted, p.7] | -227,749 [extracted, p.7] | 3,086,832 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 20,912,706 [derived, p.8] | 15,630,759 [derived, p.8] | 13,359,444 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | 1,033,904 [derived, p.8] | 602,153 [derived, p.8] | 55,397 [derived, p.8] |
| federal grants (Statement of activities) | 2,741,829 [derived, p.8] | 3,527,562 [derived, p.8] | 4,351,055 [derived, p.8] |
| other grants and contracts (Statement of activities) | 2,779,840 [derived, p.8] | 3,439,363 [derived, p.8] | 5,214,964 [derived, p.8] |
| contributions (Statement of activities) | 446,640 [derived, p.8] | 313,622 [derived, p.8] | 529,479 [derived, p.8] |
| other revenue (Statement of activities) | 726,155 [derived, p.8] | 399,269 [derived, p.8] | 343,630 [derived, p.8] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 28,641,074 [extracted, p.8] | 23,912,728 [extracted, p.8] | 23,853,969 [extracted, p.8] |
| salaries and benefits (Statement of activities) | 20,079,217 [derived, p.8] | 17,234,864 [derived, p.8] | 19,870,229 [derived, p.8] |
| supplies and pharmaceuticals (Statement of activities) | 698,076 [derived, p.8] | 327,045 [derived, p.8] | 77,487 [derived, p.8] |
| purchased and professional services (Statement of activities) | 1,555,992 [derived, p.8] | 1,750,502 [derived, p.8] | 1,714,062 [derived, p.8] |
| occupancy (Statement of activities) | 1,322,087 [derived, p.8] | 1,210,833 [derived, p.8] | 1,449,873 [derived, p.8] |
| depreciation and amortization (Statement of activities) | 488,983 [derived, p.8] | 567,745 [derived, p.8] | 499,246 [derived, p.8] |
| interest (Statement of activities) | 267,408 [derived, p.8] | 343,562 [derived, p.8] | 427,206 [derived, p.8] |
| other expenses (Statement of activities) | 6,607,879 [derived, p.8] | 4,811,697 [derived, p.8] | 4,095,122 [derived, p.8] |
| TOTAL EXPENSES (Statement of activities) | 31,019,642 [extracted, p.8] | 26,246,248 [extracted, p.8] | 28,133,225 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| non-operating and other changes (Statement of activities) | absent (not printed, or not read) | -131,456 [derived, p.8] | absent (not printed, or not read) |
| CHANGE IN NET ASSETS (Statement of activities) | -2,378,568 [extracted, p.8] | -2,464,976 [extracted, p.8] | -4,279,256 [extracted, p.8] |
| net assets, beginning (Statement of activities) | -227,749 [extracted, p.8] | 2,237,227 [extracted, p.8] | 7,366,088 [extracted, p.8] |
| net assets, end (Statement of activities) | -2,606,317 [extracted, p.8] | -227,749 [extracted, p.8] | 3,086,832 [extracted, p.8] |

| Ratio | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| Days cash on hand | 18 days [plausible] | 58 days [plausible] | 20 days [plausible] |
| Current ratio | 0.59x [plausible] | 0.76x [plausible] | 1.09x [plausible] |
| Operating margin | absent [not computed] | absent [not computed] | absent [not computed] |
| Total margin | -8.3% [plausible] | -10.3% [plausible] | -17.9% [plausible] |
| Patient revenue share | 73.0% [plausible] | 65.4% [plausible] | 56.0% [plausible] |
| Grant dependency | 19.3% [plausible] | 29.1% [plausible] | 40.1% [plausible] |
| Salaries share | 64.7% [plausible] | 65.7% [plausible] | 70.6% [plausible] |
| Days in patient receivables | 86 days [plausible] | 56 days [plausible] | 46 days [plausible] |
| Debt to net assets | -10.43x [plausible] | -107.43x [plausible] | 8.65x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Probable). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Valle Del Sol, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Valle Del Sol, Inc.", https://astrelis.co/providers/health_center/031001, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.